Cargando…

Temporal stability of quality of life assessments in cancer patients

Quality of life (QoL) is an important outcome criterion in cancer research and practice. Multiple studies have been performed to test the short-term temporal stability (1 day–2 weeks) of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-C30, but i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinz, Andreas, Schulte, Thomas, Rassler, Jörg, Zenger, Markus, Geue, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933346/
https://www.ncbi.nlm.nih.gov/pubmed/33664409
http://dx.doi.org/10.1038/s41598-021-84681-0
_version_ 1783660589768245248
author Hinz, Andreas
Schulte, Thomas
Rassler, Jörg
Zenger, Markus
Geue, Kristina
author_facet Hinz, Andreas
Schulte, Thomas
Rassler, Jörg
Zenger, Markus
Geue, Kristina
author_sort Hinz, Andreas
collection PubMed
description Quality of life (QoL) is an important outcome criterion in cancer research and practice. Multiple studies have been performed to test the short-term temporal stability (1 day–2 weeks) of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-C30, but its stability over longer periods of time is largely unknown. The EORTC QLQ-C30 was administered at two time points between 3 and 12 months apart in six samples of cancer patients with varying characteristics (N between 298 and 923). Averaged across the six samples, the coefficients of temporal stability (intra-class correlation coefficients ICC) were between 0.31 and 0.59 for the single scales. The 2-item global health/QoL scale showed a mean coefficient of 0.44. When the stability coefficients were calculated separately for males and females and for younger vs. older patients, no systematic gender or age differences were found in the temporal stability of the QoL scales, though the stability was slightly higher in males (vs. females) and in older subgroups (vs. younger subgroups). It is nearly impossible to predict the course a cancer patients’ QoL will take over a several month period. Repeated measurements are necessary to track QoL developments.
format Online
Article
Text
id pubmed-7933346
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79333462021-03-08 Temporal stability of quality of life assessments in cancer patients Hinz, Andreas Schulte, Thomas Rassler, Jörg Zenger, Markus Geue, Kristina Sci Rep Article Quality of life (QoL) is an important outcome criterion in cancer research and practice. Multiple studies have been performed to test the short-term temporal stability (1 day–2 weeks) of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-C30, but its stability over longer periods of time is largely unknown. The EORTC QLQ-C30 was administered at two time points between 3 and 12 months apart in six samples of cancer patients with varying characteristics (N between 298 and 923). Averaged across the six samples, the coefficients of temporal stability (intra-class correlation coefficients ICC) were between 0.31 and 0.59 for the single scales. The 2-item global health/QoL scale showed a mean coefficient of 0.44. When the stability coefficients were calculated separately for males and females and for younger vs. older patients, no systematic gender or age differences were found in the temporal stability of the QoL scales, though the stability was slightly higher in males (vs. females) and in older subgroups (vs. younger subgroups). It is nearly impossible to predict the course a cancer patients’ QoL will take over a several month period. Repeated measurements are necessary to track QoL developments. Nature Publishing Group UK 2021-03-04 /pmc/articles/PMC7933346/ /pubmed/33664409 http://dx.doi.org/10.1038/s41598-021-84681-0 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hinz, Andreas
Schulte, Thomas
Rassler, Jörg
Zenger, Markus
Geue, Kristina
Temporal stability of quality of life assessments in cancer patients
title Temporal stability of quality of life assessments in cancer patients
title_full Temporal stability of quality of life assessments in cancer patients
title_fullStr Temporal stability of quality of life assessments in cancer patients
title_full_unstemmed Temporal stability of quality of life assessments in cancer patients
title_short Temporal stability of quality of life assessments in cancer patients
title_sort temporal stability of quality of life assessments in cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933346/
https://www.ncbi.nlm.nih.gov/pubmed/33664409
http://dx.doi.org/10.1038/s41598-021-84681-0
work_keys_str_mv AT hinzandreas temporalstabilityofqualityoflifeassessmentsincancerpatients
AT schultethomas temporalstabilityofqualityoflifeassessmentsincancerpatients
AT rasslerjorg temporalstabilityofqualityoflifeassessmentsincancerpatients
AT zengermarkus temporalstabilityofqualityoflifeassessmentsincancerpatients
AT geuekristina temporalstabilityofqualityoflifeassessmentsincancerpatients